235 related articles for article (PubMed ID: 21698787)
1. Combined treatment for child refractory Mycoplasma pneumoniae pneumonia with ciprofloxacin and glucocorticoid.
Lu A; Wang L; Zhang X; Zhang M
Pediatr Pulmonol; 2011 Nov; 46(11):1093-7. PubMed ID: 21698787
[TBL] [Abstract][Full Text] [Related]
2. Clinical efficacy of macrolide antibiotics against genetically determined macrolide-resistant Mycoplasma pneumoniae pneumonia in paediatric patients.
Kawai Y; Miyashita N; Yamaguchi T; Saitoh A; Kondoh E; Fujimoto H; Teranishi H; Inoue M; Wakabayashi T; Akaike H; Ogita S; Kawasaki K; Terada K; Kishi F; Ouchi K
Respirology; 2012 Feb; 17(2):354-62. PubMed ID: 22077195
[TBL] [Abstract][Full Text] [Related]
3. Management of refractory Mycoplasma pneumoniae pneumonia: utility of measuring serum lactate dehydrogenase level.
Inamura N; Miyashita N; Hasegawa S; Kato A; Fukuda Y; Saitoh A; Kondo E; Teranishi H; Wakabayashi T; Akaike H; Tanaka T; Ogita S; Nakano T; Terada K; Ouchi K
J Infect Chemother; 2014 Apr; 20(4):270-3. PubMed ID: 24486173
[TBL] [Abstract][Full Text] [Related]
4. [The clinical characteristics, treatment and outcome of macrolide-resistant Mycoplasma pneumoniae pneumonia in children].
Bao F; Qu JX; Liu ZJ; Qin XG; Cao B
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Oct; 36(10):756-61. PubMed ID: 24433804
[TBL] [Abstract][Full Text] [Related]
5. Emerging macrolide resistance in Mycoplasma pneumoniae in children: detection and characterization of resistant isolates.
Li X; Atkinson TP; Hagood J; Makris C; Duffy LB; Waites KB
Pediatr Infect Dis J; 2009 Aug; 28(8):693-6. PubMed ID: 19633515
[TBL] [Abstract][Full Text] [Related]
6. Mycoplasma pneumoniae 23S rRNA A2063G mutation does not influence chest radiography features in children with pneumonia.
Deng H; Rui J; Zhao D; Liu F
J Int Med Res; 2018 Jan; 46(1):150-157. PubMed ID: 28760082
[TBL] [Abstract][Full Text] [Related]
7. Characterization of macrolide resistance of Mycoplasma pneumoniae in children in Shenzhen, China.
Ma Z; Zheng Y; Deng J; Ma X; Liu H
Pediatr Pulmonol; 2014 Jul; 49(7):695-700. PubMed ID: 23861188
[TBL] [Abstract][Full Text] [Related]
8. Emergence of macrolide-resistant Mycoplasma pneumoniae with a 23S rRNA gene mutation.
Morozumi M; Hasegawa K; Kobayashi R; Inoue N; Iwata S; Kuroki H; Kawamura N; Nakayama E; Tajima T; Shimizu K; Ubukata K
Antimicrob Agents Chemother; 2005 Jun; 49(6):2302-6. PubMed ID: 15917525
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of D-dimer levels in refractory Mycoplasma pneumoniae pneumonia.
Huang X; Li D; Liu F; Zhao D; Zhu Y; Tang H
BMC Infect Dis; 2021 Jan; 21(1):14. PubMed ID: 33407216
[TBL] [Abstract][Full Text] [Related]
10. Effects of methylprednisolone or immunoglobulin when added to standard treatment with intravenous azithromycin for refractory Mycoplasma pneumoniae pneumonia in children.
Shan LS; Liu X; Kang XY; Wang F; Han XH; Shang YX
World J Pediatr; 2017 Aug; 13(4):321-327. PubMed ID: 28130749
[TBL] [Abstract][Full Text] [Related]
11. Lactate Dehydrogenase as a Biomarker for Prediction of Refractory Mycoplasma pneumoniae Pneumonia in Children.
Lu A; Wang C; Zhang X; Wang L; Qian L
Respir Care; 2015 Oct; 60(10):1469-75. PubMed ID: 26060318
[TBL] [Abstract][Full Text] [Related]
12. [Clinical features and treatment of refractory Mycoplasma pneumoniae pneumonia unresponded to conventional dose methylprednisolone in children].
Chen L; Liu J; Zhao S; Yang Y; Wu J
Zhonghua Er Ke Za Zhi; 2014 Mar; 52(3):172-6. PubMed ID: 24824385
[TBL] [Abstract][Full Text] [Related]
13. Complicated parapneumonic effusion and empyema in children.
Shen YH; Hwang KP; Niu CK
J Microbiol Immunol Infect; 2006 Dec; 39(6):483-8. PubMed ID: 17164951
[TBL] [Abstract][Full Text] [Related]
14. Molecular characterization of macrolide resistance of a Mycoplasma pneumoniae strain that developed during therapy of a patient with pneumonia.
Dumke R; Stolz S; Jacobs E; Juretzek T
Int J Infect Dis; 2014 Dec; 29():197-9. PubMed ID: 25449256
[TBL] [Abstract][Full Text] [Related]
15. High prevalence of macrolide resistance in Mycoplasma pneumoniae isolates from adult and adolescent patients with respiratory tract infection in China.
Cao B; Zhao CJ; Yin YD; Zhao F; Song SF; Bai L; Zhang JZ; Liu YM; Zhang YY; Wang H; Wang C
Clin Infect Dis; 2010 Jul; 51(2):189-94. PubMed ID: 20540621
[TBL] [Abstract][Full Text] [Related]
16. [Clinical analysis of 20 cases with Streptococcus pneumoniae necrotizing pneumonia in China].
Liu JR; Xu BP; Li HM; Sun JH; Tian BL; Zhao SY; Jiang ZF
Zhonghua Er Ke Za Zhi; 2012 Jun; 50(6):431-4. PubMed ID: 22931940
[TBL] [Abstract][Full Text] [Related]
17. [Clinical characteristics and therapy of severe Mycoplasma pneumonia in children].
Qi JG; Zhang SJ; Chen YH
Zhongguo Dang Dai Er Ke Za Zhi; 2008 Dec; 10(6):719-22. PubMed ID: 19102838
[TBL] [Abstract][Full Text] [Related]
18. Mutations in domain V of
Xu C; Deng H; Zhang J; Zhu Y; Rong Q; Quan Y; Tang H; Zhao D
J Int Med Res; 2021 Jun; 49(6):3000605211016376. PubMed ID: 34082582
[TBL] [Abstract][Full Text] [Related]
19. [Comparative analysis of clinical characteristics and prognosis between bacterial necrotizing pneumonia and
Zhang YY; Dai LM; Zhou YL; Yang DH; Tang LF; Chen ZM
Zhonghua Er Ke Za Zhi; 2019 Aug; 57(8):625-630. PubMed ID: 31352749
[No Abstract] [Full Text] [Related]
20. Identify clinical factors related to Mycoplasma pneumoniae pneumonia with hypoxia in children.
Ling Y; Zhang T; Guo W; Zhu Z; Tian J; Cai C; Xu Y
BMC Infect Dis; 2020 Jul; 20(1):534. PubMed ID: 32698769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
